CLIMB BIO, INC. Shares Outstanding (Cover Page)
CLIMB BIO, INC. (CLYM) had Shares Outstanding (Cover Page) of 57.44 million shares as of 2026-07-31, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-07-31: Entity Common Stock, Shares Outstanding 57.44M shares.
- 2026-04-30: Entity Common Stock, Shares Outstanding 57.26M shares.
- 2026-02-27: Entity Common Stock, Shares Outstanding 47.77M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 68.18M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 57.44M shares 10-Q · filed 2026-08-06 |
| 2026-04-30 | 57.26M shares 10-Q · filed 2026-05-07 |
| 2026-02-27 | 47.77M shares 10-K · filed 2026-03-05 |
| 2025-10-31 | 68.18M shares 10-Q · filed 2025-11-06 |
| 2025-07-31 | 67.76M shares 10-Q · filed 2025-08-12 |
| 2025-05-09 | 67.58M shares 10-Q · filed 2025-05-14 |
| 2025-03-21 | 67.48M shares 10-K · filed 2025-03-25 |
| 2024-11-07 | 67.22M shares 10-Q · filed 2024-11-12 |
| 2024-08-12 | 67.06M shares 10-Q · filed 2024-08-14 |
| 2024-05-09 | 29.09M shares 10-Q · filed 2024-05-15 |
| 2024-03-31 | 27.72M shares 10-K/A · filed 2024-04-29 |
| 2024-03-27 | 27.72M shares 10-K · filed 2024-03-28 |
| 2023-11-11 | 27.57M shares 10-Q · filed 2023-11-14 |
| 2023-08-08 | 27.09M shares 10-Q · filed 2023-08-10 |
| 2023-05-09 | 26.99M shares 10-Q · filed 2023-05-11 |
| 2023-02-28 | 26.57M shares 10-K · filed 2023-03-06 |
| 2022-11-10 | 26.57M shares 10-Q · filed 2022-11-14 |
| 2022-08-12 | 26.57M shares 10-Q · filed 2022-08-15 |
| 2022-05-13 | 26.57M shares 10-Q · filed 2022-05-16 |
| 2022-02-28 | 26.57M shares 10-K · filed 2022-03-07 |
| 2021-11-05 | 26.55M shares 10-Q · filed 2021-11-08 |
| 2021-09-10 | 26.55M shares 10-Q · filed 2021-09-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |